# Biglari Holdings Inc.: financial statements, quarterly

BH-A · NYSE · CIK 1726173 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bh-a.md) · [Financials](/companies/bh-a/financials.md) · [Filings](/companies/bh-a/filings.md) · [Insiders](/companies/bh-a/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bh-a/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [90.9](/filings/0001726173-24-000041.md) | [90.7 d](/filings/0001628280-26-012987.md) | [89.5](/filings/0001726173-25-000031.md) | [91.1](/filings/0001628280-25-039267.md) | [90.4](/filings/0001628280-25-050620.md) | [91.1 d](/filings/0001628280-26-012987.md) | [95.0](/filings/0001628280-26-032880.md) | [101](/filings/0001628280-26-054841.md) | [99.7](/filings/0001628280-25-050620.md) | [99.9 d](/filings/0001628280-26-012987.md) | [97.5](/filings/0001628280-26-032880.md) | [109](/filings/0001628280-26-054841.md) |
| Cost of revenue | $m | [36.8](/filings/0001726173-24-000041.md) | [33.5 d](/filings/0001628280-26-012987.md) | [34.4](/filings/0001726173-25-000031.md) | [36.9](/filings/0001628280-25-039267.md) | [36.2](/filings/0001628280-25-050620.md) | [35.9 d](/filings/0001628280-26-012987.md) | [37.8](/filings/0001628280-26-032880.md) | [40.0](/filings/0001628280-26-054841.md) | [41.8](/filings/0001628280-25-050620.md) | [41.7 d](/filings/0001628280-26-012987.md) | [37.5](/filings/0001628280-26-032880.md) | [41.1](/filings/0001628280-26-054841.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [18.3](/filings/0001726173-24-000041.md) | [22.4 d](/filings/0001628280-26-012987.md) | [18.3](/filings/0001726173-25-000031.md) | [18.7](/filings/0001628280-25-039267.md) | [19.5](/filings/0001628280-25-050620.md) | [19.2 d](/filings/0001628280-26-012987.md) | [21.4](/filings/0001628280-26-032880.md) | [22.9](/filings/0001628280-26-054841.md) | [20.4](/filings/0001628280-25-050620.md) | [22.2 d](/filings/0001628280-26-012987.md) | [24.9](/filings/0001628280-26-032880.md) | [26.2](/filings/0001628280-26-054841.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | [6.8](/filings/0001726173-25-000031.md) | [(14.7)](/filings/0001628280-25-039267.md) | [11.2](/filings/0001628280-25-050620.md) | [(7.7) d](/filings/0001628280-26-012987.md) | [(7.9)](/filings/0001628280-26-032880.md) | [14.2](/filings/0001628280-26-054841.md) | [(2.3)](/filings/0001628280-25-050620.md) | [(14.2) d](/filings/0001628280-26-012987.md) | [(4.4)](/filings/0001628280-26-032880.md) | [11.7](/filings/0001628280-26-054841.md) |
| Net income | $m | [(56.5)](/filings/0001726173-24-000041.md) | [44.6 d](/filings/0001628280-26-012987.md) | [22.6](/filings/0001628280-25-050620.md) | [(48.2)](/filings/0001628280-25-050620.md) | [32.1](/filings/0001628280-25-050620.md) | [(10.3) d](/filings/0001628280-26-012987.md) | [(33.3)](/filings/0001628280-26-054841.md) | [50.9](/filings/0001628280-26-054841.md) | [(5.3)](/filings/0001628280-25-050620.md) | [(49.9) d](/filings/0001628280-26-012987.md) | [(14.5)](/filings/0001628280-26-054841.md) | [39.9](/filings/0001628280-26-054841.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [34.0](/filings/0001726173-24-000041.md) | [28.1](/filings/0001628280-26-012987.md) | [34.5](/filings/0001726173-25-000031.md) | [26.9](/filings/0001628280-25-039267.md) | [29.9](/filings/0001628280-25-050620.md) | [30.7](/filings/0001628280-26-012987.md) | [28.7](/filings/0001628280-26-032880.md) | [32.8](/filings/0001628280-26-054841.md) | [272](/filings/0001628280-25-050620.md) | [269](/filings/0001628280-26-054841.md) | [200](/filings/0001628280-26-032880.md) | [68.4](/filings/0001628280-26-054841.md) |
| Current assets | $m | [155](/filings/0001726173-23-000044.md) | [153](/filings/0001726173-25-000003.md) | [168](/filings/0001726173-24-000027.md) | [151](/filings/0001726173-24-000035.md) | [165](/filings/0001726173-24-000041.md) | [171](/filings/0001628280-26-012987.md) | [172](/filings/0001726173-25-000031.md) | [174](/filings/0001628280-25-039267.md) | [404](/filings/0001628280-25-050620.md) | [379](/filings/0001628280-26-054841.md) | [356](/filings/0001628280-26-032880.md) | [384](/filings/0001628280-26-054841.md) |
| Total assets | $m | [827](/filings/0001726173-23-000044.md) | [849](/filings/0001726173-25-000003.md) | [885](/filings/0001726173-24-000027.md) | [809](/filings/0001726173-24-000035.md) | [865](/filings/0001726173-24-000041.md) | [866](/filings/0001628280-26-012987.md) | [829](/filings/0001726173-25-000031.md) | [864](/filings/0001628280-25-039267.md) | [1,079](/filings/0001628280-25-050620.md) | [1,025](/filings/0001628280-26-054841.md) | [1,018](/filings/0001628280-26-032880.md) | [1,059](/filings/0001628280-26-054841.md) |
| Current liabilities | $m | [142](/filings/0001726173-23-000044.md) | [111](/filings/0001726173-25-000003.md) | [118](/filings/0001726173-24-000027.md) | [106](/filings/0001726173-24-000035.md) | [112](/filings/0001726173-24-000041.md) | [147](/filings/0001628280-26-012987.md) | [150](/filings/0001726173-25-000031.md) | [126](/filings/0001628280-25-039267.md) | [143](/filings/0001628280-25-050620.md) | [156](/filings/0001628280-26-054841.md) | [144](/filings/0001628280-26-032880.md) | [157](/filings/0001628280-26-054841.md) |
| Total liabilities | $m | [270](/filings/0001726173-23-000044.md) | [250](/filings/0001726173-25-000003.md) | [267](/filings/0001726173-24-000027.md) | [240](/filings/0001726173-24-000035.md) | [263](/filings/0001726173-24-000041.md) | [293](/filings/0001628280-26-012987.md) | [289](/filings/0001726173-25-000031.md) | [274](/filings/0001628280-25-039267.md) | [499](/filings/0001628280-25-050620.md) | [502](/filings/0001628280-26-054841.md) | [499](/filings/0001628280-26-032880.md) | [515](/filings/0001628280-26-054841.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [10.0](/filings/0001628280-26-012987.md) | not reported | not reported | [215](/filings/0001628280-25-050620.md) | [214](/filings/0001628280-26-054841.md) | [212](/filings/0001628280-26-032880.md) | [210](/filings/0001628280-26-054841.md) |
| Current portion of debt | $m | [19.0](/filings/0001726173-23-000044.md) | [0.0](/filings/0001726173-24-000035.md) | not reported | [0.1](/filings/0001726173-24-000035.md) | not reported | [35.0](/filings/0001628280-26-012987.md) | not reported | not reported | [20.9](/filings/0001628280-25-050620.md) | [33.1](/filings/0001628280-26-054841.md) | [28.3](/filings/0001628280-26-032880.md) | [28.3](/filings/0001628280-26-054841.md) |
| Shareholders' equity | $m | [557](/filings/0001726173-23-000044.md) | [599](/filings/0001628280-25-050620.md) | [619](/filings/0001628280-25-050620.md) | [569](/filings/0001628280-25-050620.md) | [602](/filings/0001628280-25-050620.md) | [573](/filings/0001628280-26-054841.md) | [540](/filings/0001628280-26-054841.md) | [589](/filings/0001628280-26-054841.md) | [580](/filings/0001628280-25-050620.md) | [523](/filings/0001628280-26-054841.md) | [519](/filings/0001628280-26-054841.md) | [544](/filings/0001628280-26-054841.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.2 d](/filings/0001726173-24-000041.md) | [24.3 d](/filings/0001628280-26-012987.md) | [19.1](/filings/0001726173-25-000031.md) | [1.8 d](/filings/0001628280-25-039267.md) | [10.8 d](/filings/0001628280-25-050620.md) | [18.0 d](/filings/0001628280-26-012987.md) | [15.8](/filings/0001628280-26-032880.md) | [42.1 d](/filings/0001628280-26-054841.md) | [31.2 d](/filings/0001628280-25-050620.md) | [17.8 d](/filings/0001628280-26-012987.md) | [20.3](/filings/0001628280-26-032880.md) | [14.9 d](/filings/0001628280-26-054841.md) |
| Capital expenditure | $m | [6.4 d](/filings/0001726173-24-000041.md) | [6.5 d](/filings/0001628280-26-012987.md) | [4.6](/filings/0001726173-25-000031.md) | [11.8 d](/filings/0001628280-25-039267.md) | [7.1 d](/filings/0001628280-25-050620.md) | [7.1 d](/filings/0001628280-26-012987.md) | [7.3](/filings/0001628280-26-032880.md) | [2.7 d](/filings/0001628280-26-054841.md) | [8.9 d](/filings/0001628280-25-050620.md) | [11.4 d](/filings/0001628280-26-012987.md) | [7.0](/filings/0001628280-26-032880.md) | [6.7 d](/filings/0001628280-26-054841.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Shares outstanding: 206,864 at 2020-11-03, from the cover of the [10-Q filed 2020-11-09](/filings/0001193805-20-001399.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.